Patient Webinar: Diffuse Large B-Cell Lymphoma

DLBCL-Webinar-Ads780x200

Free Know What Your Doctors Know patient webinar for those with diffuse large B-cell lymphoma (DLBCL), their caregivers, and their families.

Two chances to attend!

Friday, October 22, 2021 12:15 – 1:30 PM EDT

Register Now


Wednesday, October 27, 2021  3:30 – 4:45 PM EDT

Register Now


Join experts as they discuss DLBCL. You will learn about:

  • Diagnosis and prognosis
  • Initial treatment approaches
  • Novel approaches to relapsed disease
  • Accurate expectations and management of side effects
  • Navigating treatment in the COVID era
  • Shared decision-making

Each webinar will include a Question & Answer session. You may submit questions to the presenters during the webinar or in advance. Register for more details. 

Please note that this is a not an accredited activity.

For a printable flyer to disseminate to your patients, click here.

Agenda

  • Introduction
  • Expert Discussion of DLBCL
  • Question & Answer session

Presenters

  • Jeremy S. Abramson, MD, MMSc

Director, Jon and Jo Ann Hagler Center for Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School

  • Krista J. Scorsune, MSN, RN, CNP-BC

Nurse Practitioner
Massachusetts General Hospital Cancer Center

  • Susan Krivacic, MPAff

Patient Advocate
Survivor of non-Hodgkin lymphoma

Fee Information

Webinars are free to attend. A free print copy of the NCCN Guidelines for Patients®: Diffuse Large B-Cell Lymphoma, Version 2020 will be sent to the first 400 registrants to request a book. Please provide your mailing address during registration to obtain your free book in the mail. We regret that we cannot send free print copies outside of the United States.
The NCCN Guidelines for Patients are a good starting point to learn the best health care options for a type of cancer.

Supporters

This webinar program is supported through the NCCN Foundation, by contributions from our corporate supporters Incyte Corporation and MorphoSys US Inc.